LMMY Exousia Bio, Inc.

Fundamentals / CIK 0001939937 / USD

Exousia Bio, Inc. reported $0 in revenue and a net loss of $99K for the trailing twelve months ended February 28, 2026 (down 67.4% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LMMY in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$57K$28K$0-$57KFY 2023 Revenue: $0FY 2023 Net Income: -$56K2023FY 2024 Revenue: $12KFY 2024 Net Income: -$26K2024FY 2025 Revenue: $3.8KFY 2025 Net Income: $51K2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement May 31 May 31 May 31
Revenue $3.8K $12K $0
Cost of Revenue $7.3K $9.7K $0
Gross Profit -$3.5K $1.8K $0
Total Operating Expenses $32K $28K $56K
Operating Income -$35K -$26K -$56K
EBITDA -$24K -$12K -$42K
Income Before Tax $51K -$26K -$56K
Income Tax Expense $0 $0 $0
Net Income $51K -$26K -$56K
Basic EPS $0.00 $0.00 $0.00
Diluted EPS $0.00 $0.00 $0.00
Basic Shares Outstanding 7.8M 7.8M 5.7M
Diluted Shares Outstanding 7.8M 7.8M 5.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31 2024-05-31
Revenue $0 $0 $0 $0 $0 $0 $3.8K $3.8K
Cost of Revenue $62K $62K $0 $7.3K $0 $0 $0 --
Gross Profit -$62K -$62K $0 -$7.3K $0 $0 $3.8K -$5.9K
Selling, General & Admin -- $0 -- -- -- $7.0K -- --
Total Operating Expenses $175K $175K $32K $21K $7.0K $7.0K $8.1K -$228
Operating Income -$237K -$237K -$32K -$28K $7.0K $7.0K -$4.3K -$5.7K
EBITDA -$237K -$236K -$32K -$25K $7.0K $11K $1.8K -$2.0K
Interest Income -- -- $0 -- -- -- $431 --
Income Before Tax -$19K -$19K -$32K -$29K $80K $80K -$3.9K -$5.3K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$19K -$19K -$32K -$29K $80K $80K -$3.9K -$5.3K
Basic EPS $0.00 $0.00 $0.00 -- $0.01 $0.01 $0.00 --
Diluted EPS $0.00 $0.00 $0.00 -- $0.01 $0.01 $0.00 --
Basic Shares Outstanding 16.8M 16.8M 7.8M -- 7.8M 7.8M 7.8M --
Diluted Shares Outstanding 16.8M 16.8M 7.8M -- 7.8M 7.8M 7.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet May 31 May 31 May 31 May 31
Cash & Cash Equivalents -- -- $7.9K $10K
Cash & Short-Term Investments -- -- $7.9K $10K
Accounts Receivable, Net $0 $12K $0 --
Total Current Assets $0 $13K $7.9K $10K
Property, Plant & Equipment, Net $0 $5.0K $10.0K $15K
Intangible Assets $0 $9.5K $19K $29K
Other Non-Current Assets $0 -- -- --
Total Non-Current Assets $0 $14K $29K $44K
Total Assets $0 $27K $37K $54K
Accounts Payable $0 -- -- --
Other Current Liabilities $0 -- -- --
Total Current Liabilities $0 $14K $3.6K $0
Total Non-Current Liabilities $0 $68K $63K $54K
Total Liabilities $0 $82K $66K $54K
Common Stock $778 $778 $778 $500
Retained Earnings -$32K -$83K -$57K -$937
Total Stockholders' Equity $0 -$55K -$29K -$437
Total Equity $0 -$55K -$29K -$437

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31 2024-05-31
Accounts Receivable, Net $0 $0 $0 $0 $0 $15K $15K $12K
Total Current Assets $0 $0 $0 $0 $0 $18K $17K $13K
Property, Plant & Equipment, Net $670 $670 $0 $0 $0 $2.4K $3.7K $5.0K
Intangible Assets $0 $0 $0 $0 $0 $4.7K $7.1K $9.5K
Other Non-Current Assets $22.05M $22.05M -- $0 -- -- -- --
Total Non-Current Assets $22.05M $22.05M $0 $0 $0 $7.1K $11K $14K
Total Assets $22.05M $22.05M $0 $0 $0 $25K $28K $27K
Accounts Payable $212K $212K -- $0 -- -- -- --
Other Current Liabilities $1.0K $1.0K -- $0 -- -- -- --
Total Current Liabilities $261K $261K $35K $0 $0 $0 $17K $14K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $70K $68K
Total Liabilities $261K $261K $35K $0 $0 $0 $87K $82K
Common Stock $7.3K $7.0K $778 $778 $778 $778 $778 $778
Retained Earnings -$289K -$289K -$64K -$32K -$28K -$3.4K -$87K -$83K
Total Stockholders' Equity $21.79M $21.79M -$35K $0 $25K $25K -$59K -$55K
Total Equity $21.79M $21.79M -$35K $0 $25K $25K -$59K -$55K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement May 31 May 31 May 31
Net Income $51K -$26K -$56K
Depreciation & Amortization $11K $15K $15K
Change in Receivables $12K -$12K $0
Operating Cash Flow -$4.5K -$12K -$38K
Investing Cash Flow $0 $0 $0
Common Stock Issued $0 $0 $28K
Financing Cash Flow $3.5K $5.7K $36K
Net Change in Cash -$1.0K -$6.8K -$2.3K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31 2024-05-31
Net Income -$19K -$19K -$32K -$29K $80K $80K -$3.9K -$5.3K
Depreciation & Amortization $0 $568 $0 $3.7K $0 $3.7K $6.1K $3.7K
Operating Cash Flow $0 $173K $3.5K -$91K $0 $90K -$3.7K -$1.4K
Investing Cash Flow $0 -$22.05M $0 $0 $0 -$3.7K $3.7K $0
Common Stock Issued -- -- -- $0 $0 $0 $0 $0
Financing Cash Flow $0 $21.88M -$3.5K $90K $0 -$87K $0 $1.4K
Net Change in Cash $0 $0 $0 -$1.0K $0 $0 $0 $2

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth May 31 May 31 May 31
Gross Margin -93.4% 15.9% --
Operating Margin -942.5% -228.2% --
Net Profit Margin 1370.5% -224.4% --
Return on Assets (ROA) -- -94.0% -152.3%
Current Ratio -- 0.91x 2.18x
Quick Ratio -- -- 2.18x
Revenue Growth (YoY) -67.4% -- --
Gross Profit Growth (YoY) -291.0% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30 2024-08-31 2024-05-31
Gross Margin -- -- -- -93.4% -28.9% 15.0% 36.6% 15.9%
Operating Margin -- -- -- -502.5% 52.4% -103.3% -171.6% -295.6%
Net Profit Margin -- -- -- 3388.9% 2014.6% 581.5% -115.1% -224.4%
Return on Equity (ROE) -0.5% 0.0% -- -- 607.9% 266.1% -- --
Return on Assets (ROA) -0.5% 0.0% -- -- -- 266.1% -62.8% -94.0%
Current Ratio 0.00x 0.00x 0.00x -- -- -- 1.00x 0.91x
Revenue Growth (YoY) -- -- -100.0% -100.0% -100.0% -100.0% -- --
Gross Profit Growth (YoY) -- -- -100.0% -- -100.0% -100.0% -- --
Operating Income Growth (YoY) -3495.0% -3495.0% -- -- -- -- -- --
Net Income Growth (YoY) -123.8% -123.8% -- -- -- -- -- --
EPS Growth (YoY) -100.0% -100.0% -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- +91.9% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001939937) · from May 31, 2022 Data through February 28, 2026 · synced Nov 21, 2026, 05:14 UTC · Open in terminal